Molecular Determinants of Sotorasib Clinical Efficacy in KRAS^G12C-Mutated Non-Small-Cell Lung Cancer

The authors reported one of the largest integrated analyses to date of sotorasib clinical efficacy biomarkers from the Phase II CodeBreaK 100 and Phase III CodeBreaK 200 studies.